ACS
ABBV icon

Archford Capital Strategies’s AbbVie ABBV Stock Holding History

Archford Capital Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
6,013
+276
+5% +$59.4K 0.15% 122
2026
Q1 		$1.25M Buy
5,737
+461
+9% +$102K 0.14% 145
2025
Q4 		$1.21M Buy
5,276
+30
+0.6% +$6.83K 0.14% 144
2025
Q3 		$1.21M Sell
5,246
-85
-2% -$17.3K 0.14% 144
2025
Q2 		$990K Buy
5,331
+2
+0% +$372 0.13% 150
2025
Q1 		$1.12M Buy
5,329
+14
+0.3% +$2.72K 0.16% 134
2024
Q4 		$944K Sell
5,315
-266
-5% -$48.9K 0.14% 140
2024
Q3 		$1.09M Sell
5,581
-172
-3% -$32.1K 0.16% 127
2024
Q2 		$987K Sell
5,753
-7,654
-57% -$1.27M 0.16% 125
2024
Q1 		$2.44M Buy
13,407
+714
+6% +$123K 0.41% 64
2023
Q4 		$1.97M Buy
12,693
+1,810
+17% +$264K 0.36% 72
2023
Q3 		$1.62M Sell
10,883
-780
-7% -$115K 0.32% 78
2023
Q2 		$1.67M Sell
11,663
-26
-0.2% -$3.81K 0.32% 74
2023
Q1 		$1.88M Buy
11,689
+1,589
+16% +$243K 0.39% 60
2022
Q4 		$1.63M Buy
10,100
+1,402
+16% +$215K 0.38% 69
2022
Q3 		$1.17M Sell
8,698
-24
-0.3% -$3.44K 0.3% 85
2022
Q2 		$1.34M Buy
8,722
+1,039
+14% +$159K 0.34% 78
2022
Q1 		$1.26M Buy
7,683
+470
+7% +$68.3K 0.28% 85
2021
Q4 		$977K Buy
7,213
+317
+5% +$37.4K 0.22% 117
2021
Q3 		$744K Buy
6,896
+358
+5% +$40.9K 0.18% 144
2021
Q2 		$736K Buy
6,538
+429
+7% +$48.3K 0.18% 141
2021
Q1 		$653K Sell
6,109
-21,749
-78% -$2.33M 0.17% 144
2020
Q4 		$2.99M Buy
27,858
+13
+0% +$1.25K 0.69% 32
2020
Q3 		$2.44M Buy
27,845
+3
+0% +$282 0.65% 37
2020
Q2 		$2.73M Sell
27,842
-239
-0.9% -$21K 0.81% 25
2020
Q1 		$2.14M Sell
28,081
-78
-0.3% -$6.64K 0.84% 28
2019
Q4 		$2.49M Sell
28,159
-128
-0.5% -$10.6K 0.86% 30
2019
Q3 		$2.14M Buy
28,287
+30
+0.1% +$2.06K 0.8% 35
2019
Q2 		$2.06M Buy
28,257
+860
+3% +$67.6K 0.75% 35
2019
Q1 		$2.21M Sell
27,397
-282
-1% -$23.1K 0.81% 32
2018
Q4 		$2.55M Sell
27,679
-2,053
-7% -$181K 1.02% 19
2018
Q3 		$2.81M Sell
29,732
-2,411
-8% -$229K 1.02% 16
2018
Q2 		$2.98M Buy
32,143
+4,435
+16% +$433K 1.05% 17
2018
Q1 		$2.68M Buy
27,708
+35
+0.1% +$3.85K 1.12% 25
2017
Q4 		$2.68M Sell
27,673
-152
-0.5% -$14.3K 1% 25
2017
Q3 		$2.47M Buy
27,825
+137
+0.5% +$10.4K 0.93% 28
2017
Q2 		$2.01M Buy
27,688
+3
+0% +$202 0.79% 36
2017
Q1 		$1.8M Buy
27,685
+5,086
+23% +$320K 0.68% 37
2016
Q4 		$1.42M Sell
22,599
-637
-3% -$38.9K 0.6% 48
2016
Q3 		$1.47M Sell
23,236
-6,463
-22% -$418K 0.6% 47
2016
Q2 		$1.84M Buy
29,699
+1,209
+4% +$73.7K 0.97% 21
2016
Q1 		$1.63M Buy
28,490
+2,989
+12% +$167K 0.78% 36
2015
Q4 		$1.64M Buy
25,501
+18,293
+254% +$1.05M 0.75% 32
2015
Q3 		$392K Buy
7,208
+295
+4% +$19.2K 0.29% 82
2015
Q2 		$464K Sell
6,913
-1,521
-18% -$99.3K 0.33% 81
2015
Q1 		$494K Buy
8,434
+125
+2% +$7.55K 0.34% 83
2014
Q4 		$544K Sell
8,309
-61
-0.7% -$3.85K 0.4% 76
2014
Q3 		$483K Sell
8,370
-455
-5% -$25.3K 0.38% 83
2014
Q2 		$498K Sell
8,825
-934
-10% -$49K 0.39% 80
2014
Q1 		$502K Buy
+9,759
New +$493K 0.42% 77

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Archford Capital Strategies's ABBV Position: Q2 2026 in Review

Archford Capital Strategies increased its AbbVie (ABBV) stake by 4.8% in Q2 2026, buying an estimated $59.4K and bringing the position to 6,013 shares worth $1.51M. The position accounts for 0.15% of the portfolio, ranked #122.

Archford Capital Strategies first reported a position in ABBV in Q1 2014 and has held it in 50 quarters since. The position peaked at $2.99M in Q4 2020. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Archford Capital Strategies held 6,013 shares of AbbVie worth $1.51M as of Q2 2026.
  • Archford Capital Strategies bought 276 AbbVie shares in Q2 2026, an estimated $59.4K.
  • AbbVie made up 0.15% of Archford Capital Strategies's portfolio in Q2 2026, its #122 holding.
  • Archford Capital Strategies first reported a position in AbbVie in Q1 2014 and has held it in 50 quarters since.
  • Archford Capital Strategies's AbbVie position peaked at $2.99M in Q4 2020.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.